Radiopharmaceuticals for Bone Metastasis Therapy and Beyond: A Voyage from the Past to the Present and a Look to the Future-Reference-Cited by-同舟云学术

Radiopharmaceuticals for Bone Metastasis Therapy and Beyond: A Voyage from the Past to the Present and a Look to the Future

Published:2012-11 Issue:9 Volume:27 Page:535-551
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Ferreira Sara¹²,Dormehl Irene³,Botelho Maria Filomena¹⁴

Affiliation:

1. Biophysics Unit, Institute of Biomedical Research in Light and Image (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

2. School of Sciences, University of Minho, Braga, Portugal.

3. Department of Internal Medicine, University of Pretoria, Pretoria, South Africa.

4. Centre of Investigation on Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2012.1258

Reference112 articles.

1. An attractive force in metastasis

2. Bone biology and physiology: Implications for novel osteoblastic osteosarcoma treatments?

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kemik Metastazlarının Tedavisinde Radyofarmasötiklerin Rolü;Fabad Journal of Pharmaceutical Sciences;2023-05-02

2. Dosimetric Comparison of Different Radionuclides Used in Metastatic Bone Disease Treatment;Current Radiopharmaceuticals;2023-03

3. Animal Models for Bone Metastasis Study;Handbook of Animal Models and its Uses in Cancer Research;2022

4. THERAGNOSTICS OF SAMARIUM-153-EDTMP IN PATIENTS BEARING PROSTATE CANCER AND OSSEOUS SECONDARIES: PALLIATIVE BUT ALSO TUMOURICIDAL;INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH;2022-01-01

5. Added value of hybrid SPECT with CT imaging for predicting poor therapeutic efficacy of 89Sr in patients with bone metastasis;Scientific Reports;2020-12